Skip to main content
    I

    Inspire Medical Systems Inc (INSP)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $59.07
    -2.03 (-3.32%)

    Market Cap: $1.77B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Inspire Medical Systems Inc (INSP) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Inspire Medical Systems (INSP) to earn $1.30 per share in the fiscal year ending Dec 31, 2026, on revenue of $855.42M. Of 18 analysts, 4 rate the stock Buy or Strong Buy, 11 Hold and 3 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 18 ratings average 3.06, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 22% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy422.2%
    Hold1161.1%
    Sell15.6%
    Strong Sell211.1%
    Consensus
    Hold
    Total analysts
    18

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 15.4% and revenue estimates rise 2.6%.

    Fiscal year ending Dec 31, 2026
    $1.30
    EPS consensus, revenue $855.42M
    Fiscal year ending Dec 31, 2027
    $1.50
    EPS consensus, revenue $877.76M
    Next report
    May 3, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.30$1.23 to $1.3515$855.42M$850.08M to $861.90M17
    Dec 31, 2027$1.50$1.36 to $1.7015$877.76M$860.88M to $908.40M17

    Quarterly Estimates

    The EPS consensus falls from $0.73 for the quarter ending Dec 31, 2026 to $0.13 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.73$0.33 to $0.9619$247.50M$225.40M to $258.30M18
    Mar 31, 2027$0.13-$0.13 to $0.3410$192.40M$184.84M to $200.30M10

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 4 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202620
    Fiscal year ending Dec 31, 202722

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 4.0% from $1.25.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$1.30$1.25$1.25$1.25$1.25+4.3%
    Fiscal year ending Dec 31, 2027$1.50$1.54$1.54$1.54$1.54-2.7%
    Quarter ending Mar 31, 2027$0.13$0.15$0.15$0.15$0.15-16.1%

    Frequently Asked Questions About INSP

    What is the INSP stock forecast?

    Consensus analyst estimates put Inspire Medical Systems's EPS at $1.30 for the fiscal year ending Dec 31, 2026, on revenue of $855.42M. The consensus rating from 18 analysts is Hold.

    How do analysts rate INSP stock?

    Of 18 analysts covering Inspire Medical Systems, 0 rate it Strong Buy, 4 Buy, 11 Hold, 1 Sell and 2 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from INSP next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.30, with estimates from $1.23 to $1.35 from 15 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.50, with estimates from $1.36 to $1.70 from 15 analysts.

    What revenue do analysts expect from Inspire Medical Systems next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $855.42M, with estimates from $850.08M to $861.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $877.76M, with estimates from $860.88M to $908.40M.

    How many analysts cover INSP?

    18 analysts rate Inspire Medical Systems stock, and 15 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.